CL075 (3M002) is a selective TLR8 agonist with immunomodulating properties. CL075 triggers a MyD88-dependent signaling pathway to elicit production of inflammatory cytokines and type I interferons (IFNs) via activation of NF-kappaB and IRF7, respectively[1][2][3].
Molecular Weight:
243.33
Purity:
99.25
CAS Number:
[256922-53-9]
Formula:
C13H13N3S
Target:
Toll-like Receptor (TLR)
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
